US Stock MarketDetailed Quotes

ABVX Abivax S.A.

Watchlist
  • 7.160
  • +0.040+0.56%
Trading Apr 30 14:34 ET
453.82MMarket Cap-2.25P/E (TTM)

About Abivax S.A. Company

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Company Profile

SymbolABVX
Company NameAbivax S.A.
Issue Price11.60
Founded2013
CEOMr. Marc de Garidel
MarketNASDAQ
Employees69
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address7-11 Boulevard Haussmann
CityParis
ProvinceIle-de-France
CountryFrance
Zip Code75009
Phone33-1-53-83-09-63

Company Executives

  • Name
  • Position
  • Salary
  • Marc de Garidel
  • Chief Executive Officer and Chairman of the Board
  • --
  • Ida Hatoum
  • Chief People Officer
  • --
  • Sheldon Sloan
  • Chief Medical Officer
  • --
  • Pierre Courteille
  • Chief Business Officer
  • --
  • Michael Ferguson
  • Chief Commercial Officer
  • --
  • Didier Scherrer
  • Chief Scientific Officer
  • --
  • Didier Blondel
  • Chief Financial Officer and Secretary of the Board
  • --
  • Dr. Philippe Pouletty
  • Director
  • --
  • Corinna zur Bonsen-Thomas
  • Independent Director
  • --
  • Camilla Soenderby
  • Independent Director
  • --
  • Troy A. Ignelzi
  • Independent Director
  • --
  • Kinam Hong
  • Independent Director
  • --
  • Dr. June Lee, M.D.
  • Independent Director
  • --
  • Dr. Carol L. Brosgart, M.D.
  • Independent Director
  • --

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More